Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 1 Device Recall Nephros Dual Stage Ultra Filter

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 1 Device Recall Nephros Dual Stage Ultra Filter see related information
Date Initiated by Firm October 28, 2013
Date Posted December 17, 2013
Recall Status1 Terminated 3 on July 06, 2016
Recall Number Z-0490-2014
Recall Event ID 66735
Product Nephros Dual Stage Ultra Filter (DSU) Brochure
Document 60-3003
Revisions: 0, 1, 2


Product Usage: A disposable point of use water ultrafilter that delivers microbiologically pure water for washing and drinking.
Code Information Item #70-0230; 70-0231; 70-0232; 70-0234; and 70-0235  Document numbers 60-0237 (all) and 60-3003 (all)
Recalling Firm/
Manufacturer		 Nephros Inc
41 Grand Ave
River Edge NJ 07661-1947
For Additional Information Contact Ms. Eileen Sukumaran
201-343-5202
Manufacturer Reason
for Recall		 Promotional materials for non-medical water filtration products were determined to promote claims which constitute marketing the product as a medical device.
FDA Determined
Cause 2		 Labeling False and Misleading
Action Nephros Inc., sent an Urgent Medical Device Recall letter dated October 29, 2013 to all affected customers via UPS 2nd Day Air. The letter identified the affected product, problem and actions to be taken. Customer are asked to provide a customer information list, immediately remove and discard all affected product labeling materials and any independent labeling materials they have created for the affected products. Customers are instructed to complete and sign the attached Response Form to acknowledge receipt, understanding and compliance with the instruction. For questions contact the Nephros representative at 201-343-5202 x 100. The letter was also posted at : http://www.nephros.com/download/news/DSU_Recall_Letters.pdf
Quantity in Commerce 3,367 untis with affected labeling
Distribution USA Nationwide Distribution
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-